Crunching the longevity numbers – 2021 investment shows the market is booming

Raising the stakes – we overview last year's longevity investment funding and analyse just where the money's going and how much.

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

Raising the stakes – we overview last year’s longevity investment funding and analyse just where the money’s going and how much.

2021 was an exciting year in longevity, and we spent part of it on the continued development of our commercial and scientific datasets. Longevity.Technology currently has a database of over 250 longevity companies – and that list is growing all the time! As part of our analysis of the state of longevity in 2021, we reviewed any company within the current dataset that had a investment funding raise during the first 11 months of year – this totalled 45 companies.
We split the longevity investment companies as follows:

Create a free account to read this article now

Join the 12,000+ biotech, pharma and investment leaders who read Longevity.Technology. No password, no payment.

By continuing you agree to our Terms and Privacy Policy, and to receive the free Longevity.Technology newsletter. You can unsubscribe at any time.

Eleanor Garth

Editor

Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

With a keen interest in all things geroscience, Eleanor covers the biological mechanisms of aging, highlighting how interventions – from nutritional strategies to advanced therapeutics – can influence the aging process at a cellular level. She also investigates the broader implications of aging research, including the integration of longevity science into healthcare strategy and the expanding wellness economy. Her work (hopefully) provides insights into how these developments are shaping the emerging landscape of healthspan optimization and age-related innovation.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Old dogs, new funding: Dog Aging Project fetches $29m from NIH

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE